Skip to main content
. Author manuscript; available in PMC: 2009 Nov 5.
Published in final edited form as: J Natl Cancer Inst. 2008 Oct 28;100(21):1500–1510. doi: 10.1093/jnci/djn351

Figure 3.

Figure 3

Kaplan-Meier analysis of survival of athymic nude mice bearing intraperitoneal OVCAR-5 human ovarian cancer xenografts. Mice were nu/nu NCr (Animal Production Program, NCI-Frederick). The therapeutic agent was administered at a dose of 1 mg/mouse given intraperitoneally once every other day, for a total of seven doses (n=10 mice/group) using two different vehicles (lipid vehicle and phosphate-buffered saline [PBS]). The lipid vehicle (n=20 mice) and PBS (n=20 mice) were used in separate vehicle control groups following the same dosing schedule. Mice were treated with vehicle alone or with one of the therapeutic agents solubilized in the vehicles. Dotted lines indicate 95% confidence intervals.